PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsControversial stem cell centre closes

BioNews

Controversial stem cell centre closes

Published 1 November 2012 posted in News and appears in BioNews 608

Author

Dr Antony Starza-Allen

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).

A controversial stem cell therapy center operating out of Dusseldorf and Cologne, Germany, has closed. The news follows an undercover investigation by the Sunday Telegraph which claimed that the clinic offered unproven and dangerous stem cell therapies....

A controversial stem cell therapy center operating out of Düsseldorf and Cologne, Germany, has closed. The news follows an undercover investigation by the Sunday Telegraph which claimed that the clinic offered unproven and dangerous stem cell therapies to patients suffering from multiple sclerosis, spinal cord injuries, and strokes, including people from the UK.

In August last year, an 18-month-old Romanian baby died from internal bleeding after being injected in the brain with stem cells. In a separate incident three months before, a boy from Azerbaijan almost died after undergoing the same procedure, reported the newspaper.

The XCell-Center, which has not commented on its closure, opened in 2007 and charged patients up to £20,000 for procedures involving injecting stem cells into the brain, spine and other areas of the body. It continued to charge patients under a 'loophole' in the law, said the Sunday Telegraph, despite concerns about the safety and efficacy of the procedures offered.

In 2009 Germany implemented EU regulations to control the marketing of innovative biotechnological techniques, including stem cell therapies, which allowed member states to introduce their own laws to regulate non-routinely manufactured products — known as the 'hospital exemption' - under which XCell's procedures are believed to have fallen.

The Paul Ehrlich Institute, responsible for regulating and licensing biomedicine in Germany, permitted an 18-month transition period but this ran out for XCell in January 2011. Nature News reports the institute, which issued an order on 21 April prohibiting all procedures involving the transfer of stem cells, noted XCell did not then apply for licences for the procedures offered on its website.

The clinic's website says: 'Due to a new development in German law, stem cell therapy is currently not possible to perform at the XCell-Center'. It has told its patients that all appointments are cancelled until further notice.

A spokesman for the Paul Ehrlich Institute said: 'The situation is very complicated but the law on stem cell treatments has not changed. However we welcome the news that the XCell-Center is not accepting any more cases'.

If XCell wishes to continue to operate, the center will need to submit licence applications for its procedures to the institute or apply to the European Medicines Agency in 2012.

Ira Hermann, coordinator of the North Rhine Westphalia stem cell network, welcomed the closure saying that XCell was offering 'unproven treatments' and 'taking a lot of money from very vulnerable people'.

Professor Chris Mason, chair of regenerative medicine at University College London, said: 'This is excellent news for the European cell therapy industry. XCell had failed to demonstrate its treatments were either safe and effective or had scientific rationale'.

Related Articles

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
20 March 2013 • 1 minute read

Cambridge University opens Stem Cell Institute

by John Brinsley

The University of Cambridge is to open a new stem cell institute following an £8million investment from two of the UK's largest medical research funders....

Image by Bill McConkey via the Wellcome Collection. Depicts sperm swimming towards an egg.
CC BY 4.0
Image by Bill McConkey via the Wellcome Collection. Depicts sperm swimming towards an egg.
News
21 February 2013 • 2 minutes read

British lab working with controversial stem cell doctor

by Ana Pallesen

A commercial London laboratory is working with a clinic in Lebanon that uses medical techniques that are not verified by the medical community, and fall outside most countries' legal parameters...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
12 December 2012 • 2 minutes read

Nevada doctor pleads not guilty of stem cell scam

by Jess Ware

A US doctor accused of implanting stem cells into chronically ill patients pleaded not guilty at a court hearing on Thursday 13 October. Dr Ralph Conti, of Henderson, Nevada, has been accused of transplanting stem cells harvested from placental tissue into patients, at the direction of Alfred Sapse, who was falsely claiming to be a doctor....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
22 November 2012 • 1 minute read

World's first stem cell trial for stroke patients passes safety test

by Alison Cranage

A pioneering clinical trial to inject stem cells into the brains of disabled stroke patients has been cleared to progress to the next stage after no safety concerns were raised in the first three patients....

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
17 October 2012 • 1 minute read

Stem cell therapy used to treat glaucoma in rats

by Dr Lux Fatimathas

UK scientists have shown stem cells can be used to successfully stop glaucoma, an eye disorder, in rats. Stem cells were isolated from bone marrow and successfully grafted onto damaged nerves in the eye...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
15 October 2010 • 2 minutes read

Human trial to use stem cells to treat spinal cord injury

by Dr Lux Fatimathas

A patient paralysed through spinal cord injury has become the first person to receive human embryonic stem (ES) cell treatment in a clinical trial being conducted in the United States...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
Comment
15 October 2010 • 2 minutes read

Stem cell tourism - don't believe the hype

by Claire Bale and 1 others

Thousands of people with serious, long term health conditions are tempted abroad each year by untested stem cell treatments. Untested stem cell treatments for Parkinson's are available in several countries, including clinics in Germany and China. But the treatments are expensive - often many thousands of pounds - and come without any scientific evidence that they work and with real risks...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
7 May 2010 • 1 minute read

Multiple Sclerosis stem cell therapy guidelines launched

by Dr Nadeem Shaikh

On 6th May 2010, the journal Nature Reviews Neurology published a new report about the future of multiple sclerosis (MS). The guidelines focus on the use of stem cell therapy. They were written by a group of international experts on the disease...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
16 April 2010 • 1 minute read

Stem cell doctor exploited 'vulnerable' patients, hearing finds

by Dr Antony Starza-Allen

The UK's General Medical Council (GMC) has ruled that a UK-registered doctor has exploited a number of vulnerable patients who have multiple sclerosis, offering unproven treatments using stem cells not suitable for human use....

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
7 March 2010 • 1 minute read

US stem-cell therapy gets helping hand from FDA

by Harriet Vickers

A US company has been granted beneficial 'orphan drug' status by the American Food and Drug Administration (FDA) for an embryonic stem cell therapy it's developing to treat a rare form of blindness...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« HFEA publishes multiple birth report

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856